Interleukin-6 stimulates LDL receptor gene expression via activation of sterol-responsive and Sp1 binding elements
- PMID: 10894816
- DOI: 10.1161/01.atv.20.7.1777
Interleukin-6 stimulates LDL receptor gene expression via activation of sterol-responsive and Sp1 binding elements
Abstract
Inflammatory or malignant diseases are associated with elevated levels of cytokines and abnormal low density lipoprotein (LDL) cholesterol metabolism. In the acute-phase response to myocardial injury or other trauma or surgery, total and LDL cholesterol levels are markedly decreased. We investigated the effects of the proinflammatory cytokine interleukin (IL)-6 on LDL receptor (LDL-R) function and gene expression in HepG2 cells. IL-6 dose-dependently increased the binding, internalization, and degradation of (125)I-LDL. IL-6-stimulated HepG2 cells revealed increased steady-state levels of LDL-R mRNA. In HepG2 cells transiently transfected with reporter gene constructs harboring the sequence of the LDL-R promoter extending from nucleotide -1563 (or from nucleotide -234) through -58 relative to the translation start site, IL-6 dose-dependently increased promoter activity. In the presence of LDL, a similar relative stimulatory effect of IL-6 was observed. Studies using a reporter plasmid with a functionally disrupted sterol-responsive element (SRE)-1 revealed a reduced stimulatory response to IL-6. In gel-shift assays, nuclear extracts of IL-6-treated HepG2 cells showed an induced binding of SRE binding protein (SREBP)-1a and SRE binding protein(SREBP)-2 to the SRE-1 that was independent of the cellular sterol content and an induced binding of Sp1 and Sp3 to repeat 3 of the LDL-R promoter. Our data indicate that IL-6 induces stimulation of the LDL-R gene, resulting in enhanced gene transcription and LDL-R activity. This effect is sterol independent and involves, on the molecular level, activation of nuclear factors binding to SRE-1 and the Sp1 binding site in repeat 2 and repeat 3 of the LDL-R promoter, respectively.
Similar articles
-
Involvement of Sp1 and SREBP-1a in transcriptional activation of the LDL receptor gene by insulin and LH in cultured porcine granulosa-luteal cells.Am J Physiol Endocrinol Metab. 2004 Jul;287(1):E128-35. doi: 10.1152/ajpendo.00400.2003. Epub 2004 Mar 2. Am J Physiol Endocrinol Metab. 2004. PMID: 14998783
-
Sterol-independent, sterol response element-dependent, regulation of low density lipoprotein receptor gene expression.J Lipid Res. 1998 Aug;39(8):1647-54. J Lipid Res. 1998. PMID: 9717725
-
SREBP-1c and Sp1 interact to regulate transcription of the gene for phosphoenolpyruvate carboxykinase (GTP) in the liver.J Biol Chem. 2004 Apr 9;279(15):15385-95. doi: 10.1074/jbc.M309905200. Epub 2004 Jan 26. J Biol Chem. 2004. PMID: 14744869
-
Regulation of intracellular cholesterol metabolism.Cell Struct Funct. 1995 Dec;20(6):421-7. doi: 10.1247/csf.20.421. Cell Struct Funct. 1995. PMID: 8825062 Review.
-
The influence of molecular biology on our understanding of lipoprotein metabolism and the pathobiology of atherosclerosis.Adv Genet. 1995;32:141-98. doi: 10.1016/s0065-2660(08)60205-9. Adv Genet. 1995. PMID: 7741021 Review. No abstract available.
Cited by
-
Mechanisms of Myocardial Damage Due to Hyperlipidemia: A Review of Recent Studies.Med Sci Monit. 2022 Sep 16;28:e937051. doi: 10.12659/MSM.937051. Med Sci Monit. 2022. PMID: 36110037 Free PMC article. Review.
-
Persistence of an atherogenic lipid profile after treatment of acute infection with Brucella.J Lipid Res. 2009 Dec;50(12):2532-9. doi: 10.1194/jlr.P900063-JLR200. Epub 2009 Jun 17. J Lipid Res. 2009. PMID: 19535817 Free PMC article. Clinical Trial.
-
Citrobacter rodentium Subverts ATP Flux and Cholesterol Homeostasis in Intestinal Epithelial Cells In Vivo.Cell Metab. 2017 Nov 7;26(5):738-752.e6. doi: 10.1016/j.cmet.2017.09.003. Epub 2017 Oct 5. Cell Metab. 2017. PMID: 28988824 Free PMC article.
-
LOX-1, a new marker of risk and prognosis in coronary artery disease?Mol Cell Biochem. 2013 Nov;383(1-2):223-30. doi: 10.1007/s11010-013-1770-z. Epub 2013 Aug 11. Mol Cell Biochem. 2013. PMID: 23934117 Review.
-
Effect of IL-6R blockade on plasma lipids and clinical outcomes among hospitalized patients with COVID-19 infection.J Lipid Res. 2024 Jun;65(6):100568. doi: 10.1016/j.jlr.2024.100568. Epub 2024 May 23. J Lipid Res. 2024. PMID: 38795859 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources